Telemedicine for Patients With Systemic Lupus Erythematosus
Author Information
Author(s): de Azevedo Cardoso Taiane, Patlolla Sridhar Reddy, Bruera Sebastian MD, Staggers Kristen Andrews MS, Suarez-Almazor Maria Eugenia MD, PhD, Agarwal Sandeep Krishna MD, PhD
Primary Institution: Baylor College of Medicine
Hypothesis
Patients with SLE in this system will have lower no-show rates with telemedicine modalities compared to in-person visits.
Conclusion
Telemedicine visits had decreased odds of no-shows without difference in laboratory testing adherence after adjustment for covariates.
Supporting Evidence
- In 2020, the no-show rate for telemedicine was 5.5% compared to 16.2% for in-person visits.
- After multivariable adjustment, the odds of no-show were lower for telemedicine visits.
- Most patients were female and had a median age of 43 years.
Takeaway
Using telemedicine for lupus check-ups means fewer missed appointments, which is good for patients who might have trouble getting to the doctor.
Methodology
Retrospective cohort study comparing no-show rates for telemedicine and in-person visits.
Potential Biases
Potential bias due to the predominance of telephone encounters and lack of control for insurance type.
Limitations
The study did not adjust for disease severity and had a predominance of telephone encounters over video visits.
Participant Demographics
Most participants were female (90.4%), Hispanic (49.3%), with a median age of 43 years.
Statistical Information
P-Value
0.002
Confidence Interval
0.20-0.77
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website